PositiveID Adds List
PositiveID Adds Listeria to Pathogens Detected by FireflyDX Onsite Detection Prototype
July 18, 2018 08:31 ET | PositiveID Corporation
FireflyDX prototype can also detect E. coli and other pathogens in minutes DELRAY BEACH, Fla., July 18, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation’s (“PositiveID” or “Company”) (OTC:PSID)...
PositiveID Subsidiar
PositiveID Subsidiary Chief Science Officer Joins Cambridge Healthtech Institute’s 26th Biodetection Technologies: Biothreat and Pathogen Detection
June 25, 2018 08:00 ET | PositiveID Corporation
DELRAY BEACH, Fla., June 25, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID) announced today its ExcitePCR subsidiary has joined Cambridge Healthtech...
PositiveID CEO Detai
PositiveID CEO Details New Distribution Agreement with Leading Non-Invasive Patient Monitoring Technology Company
June 20, 2018 08:15 ET | PositiveID Corporation
DELRAY BEACH, Fla., June 20, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (the “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today a new interview...
American CryoStem Posts Letter to Shareholders
January 06, 2014 13:45 ET | American CryoStem Corp.
EATONTOWN, N.J., Jan. 6, 2014 (GLOBE NEWSWIRE) -- John Arnone, Chairman and CEO of American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented...
American CryoStem and Protein Genomics Form Autogenesis Corporation to Support Development of Unique Stem Cell-Based Wound Products
November 14, 2013 08:30 ET | American CryoStem Corp.
EATONTOWN, N.J., Nov. 14, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
American CryoStem Opens Adipose Tissue Collection Centers at Dr. Park Avenue Cosmetic Surgery Clinics Across New Jersey
September 25, 2013 08:57 ET | American CryoStem Corp.
EATONTOWN, N.J., Sept. 25, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
American CryoStem Granted IRB Approval for Adipose Derived Stem Cell Processing Protocols
July 10, 2013 08:30 ET | American CryoStem Corp.
EATONTOWN, N.J., July 10, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
American CryoStem to Present at OneMedForumNY 2013
June 26, 2013 09:35 ET | American CryoStem Corp.
EATONTOWN, N.J., June 26, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
American CryoStem Welcomes Noted Cryopreservation Expert, Dr. Dayong Gao, to Medical & Scientific Advisory Board
June 24, 2013 08:30 ET | American CryoStem Corp.
EATONTOWN, N.J., June 24, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
American CryoStem to Present at National Investment Banking Association's 126th Investment Conference
June 04, 2013 08:30 ET | American CryoStem Corp.
EATONTOWN, N.J., June 4, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...